Stericycle Statistics
Total Valuation
Stericycle has a market cap or net worth of $5.75 billion. The enterprise value is $7.65 billion.
| Market Cap | 5.75B |
| Enterprise Value | 7.65B |
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024, before market open.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stericycle has 92.84 million shares outstanding. The number of shares has increased by 0.68% in one year.
| Current Share Class | 92.84M |
| Shares Outstanding | 92.84M |
| Shares Change (YoY) | +0.68% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 90.31% |
| Float | 92.28M |
Valuation Ratios
The trailing PE ratio is 283.97 and the forward PE ratio is 23.48.
| PE Ratio | 283.97 |
| Forward PE | 23.48 |
| PS Ratio | 2.18 |
| Forward PS | 2.04 |
| PB Ratio | 2.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 54.08 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 378.66 |
| EV / Sales | 2.91 |
| EV / EBITDA | 18.61 |
| EV / EBIT | 38.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.20 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 3.39 |
| Debt / FCF | n/a |
| Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is 0.80% and return on invested capital (ROIC) is 2.83%.
| Return on Equity (ROE) | 0.80% |
| Return on Assets (ROA) | 2.30% |
| Return on Capital (ROIC) | 2.83% |
| Revenue Per Employee | $194,585 |
| Profits Per Employee | $1,496 |
| Employee Count | 13,500 |
| Asset Turnover | 0.49 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Stericycle has paid $19.10 million in taxes.
| Income Tax | 19.10M |
| Effective Tax Rate | 48.60% |
Stock Price Statistics
The stock price has increased by +46.77% in the last 52 weeks. The beta is 1.10, so Stericycle's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +46.77% |
| 50-Day Moving Average | 60.87 |
| 200-Day Moving Average | 55.02 |
| Relative Strength Index (RSI) | 79.11 |
| Average Volume (20 Days) | 954,099 |
Short Selling Information
The latest short interest is 4.41 million, so 4.75% of the outstanding shares have been sold short.
| Short Interest | 4.41M |
| Short Previous Month | 4.00M |
| Short % of Shares Out | 4.75% |
| Short % of Float | 4.78% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
In the last 12 months, Stericycle had revenue of $2.63 billion and earned $20.20 million in profits. Earnings per share was $0.22.
| Revenue | 2.63B |
| Gross Profit | 1.00B |
| Operating Income | 197.80M |
| Pretax Income | 57.60M |
| Net Income | 20.20M |
| EBITDA | 411.10M |
| EBIT | 197.80M |
| Earnings Per Share (EPS) | $0.22 |
Balance Sheet
The company has $34.30 million in cash and $1.93 billion in debt, giving a net cash position of -$1.89 billion or -$20.41 per share.
| Cash & Cash Equivalents | 34.30M |
| Total Debt | 1.93B |
| Net Cash | -1.89B |
| Net Cash Per Share | -$20.41 |
| Equity (Book Value) | 2.55B |
| Book Value Per Share | 27.53 |
| Working Capital | 139.20M |
Cash Flow
In the last 12 months, operating cash flow was $106.40 million and capital expenditures -$137.40 million, giving a free cash flow of -$31.00 million.
| Operating Cash Flow | 106.40M |
| Capital Expenditures | -137.40M |
| Free Cash Flow | -31.00M |
| FCF Per Share | -$0.33 |
Margins
Gross margin is 38.08%, with operating and profit margins of 7.53% and 0.77%.
| Gross Margin | 38.08% |
| Operating Margin | 7.53% |
| Pretax Margin | 1.50% |
| Profit Margin | 0.77% |
| EBITDA Margin | 15.65% |
| EBIT Margin | 7.53% |
| FCF Margin | -2.63% |
Dividends & Yields
Stericycle does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.68% |
| Shareholder Yield | -0.68% |
| Earnings Yield | 0.35% |
| FCF Yield | -0.54% |
Analyst Forecast
The average price target for Stericycle is $74.00, which is 19.39% higher than the current price. The consensus rating is "Hold".
| Price Target | $74.00 |
| Price Target Difference | 19.39% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 4.34% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 1, 2007. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2007 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Stericycle has an Altman Z-Score of 1.96 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.96 |
| Piotroski F-Score | 6 |